1
Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers
Condition(s):HealthyLast Updated:December 14, 2018Completed
Alprazolam: 88 Clinical Trials
Hide Studies Not Open or Pending
2
Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet
Condition(s):Anxiety DisorderLast Updated:May 24, 2011Completed
3
Bioequivalence of Alprazolam Sublingual vs Oral Tablets
Condition(s):HealthyLast Updated:November 11, 2009Completed
4
Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation
Condition(s):HealthyLast Updated:May 29, 2012Withdrawn
5
Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets
Condition(s):HealthyLast Updated:November 23, 2009Completed
6
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions
Condition(s):HealthyLast Updated:August 23, 2010Completed
7
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions
Condition(s):HealthyLast Updated:August 23, 2010Completed
8
Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions
Condition(s):HealthyLast Updated:November 23, 2009Completed
9
Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation
Condition(s):HealthyLast Updated:December 1, 2018Withdrawn
10
Effect of Alprazolam on the Success of Inferior Alveolar Nerve (IAN) Block
Condition(s):Inferior Alveolar Nerve Block FailureLast Updated:March 6, 2012Completed
11
A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks
Condition(s):Panic DisorderLast Updated:April 7, 2008Terminated
12
A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions
Condition(s):HealthyLast Updated:November 3, 2018Withdrawn
13
Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation
Condition(s):HealthyLast Updated:March 11, 2015Withdrawn
14
Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety.
Condition(s):Generalized Anxiety DisorderLast Updated:July 26, 2019Recruiting
15
Staccato Alprazolam and Photoparoxysmal Response
Condition(s):EpilepsyLast Updated:March 13, 2017Completed
16
A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions
Condition(s):HealthyLast Updated:August 13, 2010Completed
17
A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions
Condition(s):HealthyLast Updated:August 13, 2010Completed
18
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions
Condition(s):HealthyLast Updated:June 18, 2009Completed
19
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions
Condition(s):HealthyLast Updated:September 1, 2009Completed
20
Premedication With Alprazolam and Midazolam for Upper Gastrointestinal Endoscopy
Condition(s):Diagnostic EsophagogastroduodenoscopyLast Updated:April 23, 2017Completed
21
Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment
Condition(s):Panic DisorderLast Updated:April 21, 2009Completed
22
A Study to Assess the Long-Term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder
Condition(s):Panic DisorderLast Updated:April 7, 2008Terminated
23
PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)
Condition(s):Anxiety DisordersLast Updated:December 19, 2014Completed
24
Bioequivalence Trial of Alprazolam 0.25 mg Tablets
Condition(s):Anxiety DisordersLast Updated:June 12, 2017Completed
25
Bioequivalence Trial of Alprazolam 0.5 mg Tablets
Condition(s):Anxiety DisordersLast Updated:June 12, 2017Completed
26
Bioequivalence Trial of Alprazolam 2 mg Tablets
Condition(s):Anxiety DisordersLast Updated:June 19, 2017Completed
27
An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites
Condition(s):Healthy SubjectsLast Updated:May 22, 2012Completed
28
Abuse Liability of Staccato Alprazolam
Condition(s):Abuse Liability of Staccato AlprazolamLast Updated:March 20, 2009Completed
29
Staccato Alprazolam in Panic Attack
Condition(s):Treatment of Induced Panic AttackLast Updated:June 15, 2017Completed
30
Alprazolam and Eating Behavior in Anorexia Nervosa
Condition(s):Anorexia NervosaLast Updated:November 1, 2012Completed
31
A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder
Condition(s):Panic DisorderLast Updated:April 7, 2008Terminated
32
Staccato Alprazolam Single Dose PK
Condition(s):HealthyLast Updated:March 10, 2017Completed
33
Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population
Condition(s):PharmacokineticsLast Updated:September 30, 2009Completed
34
To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg
Condition(s):AnxietyLast Updated:March 27, 2017Completed
35
To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg
Condition(s):AnxietyLast Updated:March 27, 2017Completed
36
Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy
Condition(s):Diagnostic EsophagogastroduodenoscopyLast Updated:October 16, 2013Completed
37
A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets
Condition(s):HealthyLast Updated:October 25, 2011Completed
38
Premedication With Melatonin and Alprazolam Combination Versus Alprazolam or Melatonin Alone
Condition(s):AnxietyLast Updated:September 6, 2012Completed
39
Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T
Condition(s):Psychotropic Drugs EffectsLast Updated:December 10, 2012Unknown status
40
Fed Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg
Condition(s):HealthyLast Updated:March 31, 2008Completed
41
Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg
Condition(s):HealthyLast Updated:March 31, 2008Completed
42
Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg
Condition(s):HealthyLast Updated:March 31, 2008Completed
43
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
Condition(s):Type 1 DiabetesLast Updated:September 10, 2019Completed
44
Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder
Condition(s):Generalized Anxiety Disorder; Panic DisorderLast Updated:October 17, 2014Completed
45
Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern
Condition(s):EpilepsyLast Updated:November 25, 2019Active, not recruiting
46
A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety
Condition(s):ANXIETYLast Updated:August 29, 2013Completed
47
A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients
Condition(s):Panic DisorderLast Updated:October 19, 2007Completed
48
Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam
Condition(s):Cannabis Use DisorderLast Updated:June 13, 2018Completed
49
A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder
Condition(s):Generalized Anxiety DisorderLast Updated:February 17, 2010Completed
50
Assessment of Effect of Rapastinel on Driving Performance
Condition(s):Driving PerformanceLast Updated:July 9, 2019Completed
51
Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure
Condition(s):Dental AnxietyLast Updated:March 19, 2008Completed
52
Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2
Condition(s):Type 1 DiabetesLast Updated:December 10, 2014Completed
53
Preoperative Hypnosis Versus Premedication in Gynecological Surgery
Condition(s):Gynecologic Disease; Anxiety DiseaseLast Updated:April 23, 2018Not yet recruiting
54
Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder
Condition(s):Generalized Anxiety DisorderLast Updated:June 28, 2019Completed
55
A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users
Condition(s):Healthy VolunteerLast Updated:April 30, 2018Completed
56
Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety
Condition(s):Anxiety Disorder; Panic DisorderLast Updated:June 23, 2005Completed
57
Opiates and Benzodiazepines on Driving
Condition(s):Driving BehaviorLast Updated:August 28, 2018Completed
58
Evaluation Of PF-00572778 And Alprazolam On Naloxone Challenge In Healthy Subjects
Condition(s):HealthyLast Updated:September 11, 2009Terminated
59
A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder
Condition(s):Social PhobiaLast Updated:August 2, 2017Completed
60
To Investigate Effects GSK561679 on Part of the Body’s System That Controls the Balance of Many of the Hormones.
Condition(s):Depressive Disorder and Anxiety DisordersLast Updated:September 7, 2017Completed
61
Sedative-Anxiolytic Effects on Simulated Driving Performance
Condition(s):Psychomotor ImpairmentLast Updated:May 14, 2019Completed
62
Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.
Condition(s):Generalized Anxiety DisorderLast Updated:November 9, 2009Completed
63
Spectroscopic Imaging at 4T: A Drug Challenge Study
Condition(s):AOD Effects and ConsequencesLast Updated:March 24, 2017Terminated
64
Sedative Premedication in Coronary Angiography
Condition(s):Coronary Angiography; Sedative PremedicationLast Updated:October 11, 2018Not yet recruiting
65
Reassessment of Premedication in Surgery
Condition(s):AnxietyLast Updated:September 24, 2013Completed
66
Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes
Condition(s):Type 1 Diabetes MellitusLast Updated:August 14, 2019Recruiting
67
Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder
Condition(s):Anxiety DisorderLast Updated:May 19, 2015Withdrawn
68
D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD
Condition(s):Stress Disorder, Post TraumaticLast Updated:January 6, 2016Completed
69
A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users
Condition(s):Recreational Drug Use; Prescription Drug Abuse (Not Dependent)Last Updated:December 11, 2017Completed
70
The Effects of Lasmiditan on Simulated Driving Performance – Healthy Participants
Condition(s):MigraineLast Updated:January 11, 2018Completed
71
A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects
Condition(s):HealthyLast Updated:May 25, 2012Completed
72
A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
Condition(s):Alzheimer’s Disease; Huntington’s DiseaseLast Updated:February 20, 2013Completed
73
Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free)
Condition(s):Post-operative DeliriumLast Updated:October 15, 2018Completed
74
MEOPA Breathing Analgesia for Oocyte Retrieval(KALOVAL)
Condition(s):Infertility; PainLast Updated:September 15, 2012Completed
75
Psychopharmacology of Fear-Potentiated Startle in Humans
Condition(s):HealthyLast Updated:July 3, 2018Completed
76
MELA Study – Hedonic Study on the Taste of Drugs Crushed in Food: Observational Study Involving 16 Healthy Volunteers
Condition(s):HealthyLast Updated:October 6, 2015Completed
77
The Acute Effect of Hypericum Perforatum on Short-Term Memory in Healthy Adults
Condition(s):Subclinical Anxious Adults; Nootropic Potential of Hypericum and Alprazolam; Healthy AdultsLast Updated:September 12, 2018Completed
78
Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly
Condition(s):Sleep DisordersLast Updated:January 7, 2016Unknown status
79
Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers
Condition(s):Anxiety DisordersLast Updated:July 3, 2018Completed
80
Licorice Botanical Dietary Supplements – Metabolism and Safety in Women
Condition(s):Food-drug InteractionLast Updated:May 15, 2019Recruiting
81
Treatment of Chronic Migraine Headaches.
Condition(s):Chronic Migraine Without Aura, Intractable; Migraine With Typical Aura; Migraine DisordersLast Updated:April 2, 2018Unknown status
82
Effects of Hallucinogens and Other Drugs on Mood and Performance
Condition(s):HealthyLast Updated:May 15, 2019Completed
83
Clarithromycin for the Treatment of Hypersomnia
Condition(s):Hypersomnia; Idiopathic Hypersomnia; NarcolepsyLast Updated:October 5, 2017Completed
84
Flumazenil for the Treatment of Primary Hypersomnia
Condition(s):Hypersomnia; Primary Hypersomnia; Idiopathic Hypersomnia; Narcolepsy Without CataplexyLast Updated:November 6, 2017Completed
85
Influence of Anesthesia Technique on Postoperative Evolution After Urogenital Surgical Interventions
Condition(s):Anesthesia; Reaction; Adverse Effect of Other General Anesthetics; Adverse Anesthesia Outcome; Acute Kidney InjuryLast Updated:July 15, 2013Unknown status
86
ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder
Condition(s):Generalized Anxiety DisorderLast Updated:June 29, 2010Completed
87
Pharmacovigilance in Gerontopsychiatric Patients
Condition(s):Dementia; Depression; Schizophrenia; Psychosomatic Disorders; Anxiety DisordersLast Updated:February 27, 2018Terminated
88
Gabapentin Treatment of Benzodiazepine Dependence
Condition(s):Benzodiazepine DependenceLast Updated:April 22, 2019Terminated